Earnings Date
EPS
Quarterly Revenue
Annual Revenue (as of Oct 31)
Earnings Recap
KalVista Pharma (NASDAQ:KALV) reported its Q2 earnings results on Thursday, December 7, 2023 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
KalVista Pharma missed estimated earnings by 1.27%, reporting an EPS of $-0.8 versus an estimate of $-0.79.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.12 which was followed by a 4.52% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Earnings History
Analyze the earnings history of KalVista Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
03/07/2024 | AM | KALV | Q3 | -$0.75 | — | — | — | $0.00 | — | — | — | Get Alert |
12/07/2023 | AM | KALV | Q2 | -$0.90 | -$0.79 | -$0.80 | -1.27% | $0.00 | — | $0.00 | — | Get Alert |
09/07/2023 | AM | KALV | Q1 | -$0.94 | -$0.86 | -$0.74 | 1395.35% | $0.00 | — | $0.00 | — | Get Alert |
07/07/2023 | AM | KALV | Q4 | -$0.98 | -$0.94 | -$0.77 | 18.09% | $0.00 | — | $0.00 | — | Get Alert |
03/09/2023 | AM | KALV | Q3 | -$0.92 | -$0.98 | -$0.75 | 23.47% | $0.00 | — | $0.00 | — | Get Alert |
12/08/2022 | AM | KALV | Q2 | -$0.80 | -$1.06 | -$0.90 | 15.09% | $0.00 | — | $0.00 | — | Get Alert |
09/08/2022 | AM | KALV | Q1 | -$0.66 | -$1.04 | -$0.94 | 9.62% | $0.00 | — | $0.00 | — | Get Alert |
07/07/2022 | AM | KALV | Q4 | -$0.65 | -$1.09 | -$0.98 | 10.09% | $0.00 | — | $0.00 | — | Get Alert |
03/10/2022 | AM | KALV | Q3 | -$0.56 | -$0.93 | -$0.92 | 1.08% | $0.00 | — | $0.00 | — | Get Alert |
12/09/2021 | AM | KALV | Q2 | -$0.58 | -$0.79 | -$0.80 | -1.27% | $0.00 | — | $0.00 | — | Get Alert |
09/09/2021 | AM | KALV | Q1 | -$0.61 | -$0.71 | -$0.66 | 7.04% | $0.00 | — | $0.00 | — | Get Alert |
07/13/2021 | AM | KALV | Q4 | -$0.37 | -$0.56 | -$0.65 | -16.07% | $3.82M | $580.00K | $0.00 | -100.00% | Get Alert |
03/11/2021 | AM | KALV | Q3 | -$0.52 | — | -$0.56 | — | $1.58M | — | $0.00 | — | Get Alert |
12/10/2020 | AM | KALV | Q2 | -$0.33 | — | -$0.58 | — | $3.92M | — | $0.00 | — | Get Alert |
09/14/2020 | AM | KALV | Q1 | -$0.42 | — | -$0.61 | — | $3.37M | — | $0.00 | — | Get Alert |
07/01/2020 | AM | KALV | Q4 | -$0.49 | — | -$0.37 | — | $2.93M | — | $3.82M | — | Get Alert |
03/10/2020 | AM | KALV | Q3 | -$0.23 | — | -$0.52 | — | $3.89M | — | $1.58M | — | Get Alert |
12/03/2019 | AM | KALV | Q2 | -$0.22 | — | -$0.33 | — | $5.59M | — | $3.92M | — | Get Alert |
09/09/2019 | AM | KALV | Q1 | -$0.47 | — | -$0.42 | — | $3.72M | — | $3.37M | — | Get Alert |
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma (KALV) is scheduled to report earnings on March 7, 2024. The last reported earnings were for reported on December 7, 2023 for Q2.
What were the latest earnings per share (EPS) for KalVista Pharma (NASDAQ:KALV)?
The Actual EPS was $-0.80, which missed the estimate of $-0.79.
What were KalVista Pharma’s (NASDAQ:KALV) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.